Literature DB >> 29882478

Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset.

Marco Puthenparampil1, Antonio Zito2, Giorgia Pantano3, Lisa Federle4, Erica Stropparo2, Silvia Miante2, Giustina De Silvestro5, Mario Plebani3, Paolo Gallo2.   

Abstract

BACKGROUND: Alteration of T-follicular helper (TFH) and regulatory (TFR) subpopulations may contribute to the development of auto-reactive B-cell.
OBJECTIVE: To investigate whether changes in TFH and TFR subsets are associated with abnormal IgG synthesis in blood and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients.
METHODS: Paired blood and CSF samples were obtained from 31 untreated relapsing-remitting multiple sclerosis (RRMS) patients at diagnosis. Peripheral blood TFH (CD3+CD4+CXCR5+CD25-CD127+), TFR (CD3+CD4+CXCR5+CD25+CD127dim), conventional T-Helper (TH, CD3+CD4+CXCR5-CD25-CD127+), and regulatory T-cells (T-Reg, CD3+CD4+CXCR5-CD25+CD127dim) were analyzed in all RRMS patients and in 13 healthy controls (HCs). Qualitative and quantitative intrathecal IgG synthesis was evaluated in RRMS patients, who were then further subclassified according to the presence of IgG oligoclonal bands in blood and/or CSF.
RESULTS: Compared to HC, RRMS had lower TFR percentage ( p < 0.01) and higher TFH/TFR ratio ( p < 0.001). In RRMS, TFH/TFR ratio correlated with both qualitative ( r = 0.56, p < 0.005) and quantitative intrathecal IgG synthesis (IgG Index: r = 0.78; IgGLoc: r = 0.79; IgGIF: r = 0.76, all p < 0.001). Patients with the highest TFH/TFR ratios had higher percentages of circulating B-cells (36.1 ± 35.2%, p < 0.05).
CONCLUSION: In RRMS, increased TFH/TFR ratio associates with abnormal IgG production in blood and CSF, suggesting that antibody-producing cells, derived from deregulated peripheral germinal center reaction, colonize the CNS.

Entities:  

Keywords:  Multiple sclerosis; follicular T-cell subsets; oligoclonal IgG synthesis

Mesh:

Substances:

Year:  2018        PMID: 29882478     DOI: 10.1177/1352458518779951

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis.

Authors:  Marina Rode von Essen; Rikke Holm Hansen; Camilla Højgaard; Cecilie Ammitzbøll; Heinz Wiendl; Finn Sellebjerg
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-06-07

2.  Immune and Inflammatory Determinants Underlying Alzheimer's Disease Pathology.

Authors:  Janet E Baulch; Munjal M Acharya; Sudhanshu Agrawal; Lauren A Apodaca; Clarice Monteiro; Anshu Agrawal
Journal:  J Neuroimmune Pharmacol       Date:  2020-02-24       Impact factor: 4.147

Review 3.  Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells.

Authors:  Tingting Ding; Rui Su; Ruihe Wu; Hongwei Xue; Yanyan Wang; Ronghui Su; Chong Gao; Xiaofeng Li; Caihong Wang
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

Review 4.  Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases.

Authors:  He Hao; Shingo Nakayamada; Yoshiya Tanaka
Journal:  Inflamm Regen       Date:  2021-05-03

Review 5.  Follicular Helper CD4+ T Cells, Follicular Regulatory CD4+ T Cells, and Inducible Costimulator and Their Roles in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  Xue Zhang; Ruli Ge; Hongliang Chen; Maxwell Ahiafor; Bin Liu; Jinbo Chen; Xueli Fan
Journal:  Mediators Inflamm       Date:  2021-09-12       Impact factor: 4.711

6.  Imbalance of Circulatory T Follicular Helper and T Follicular Regulatory Cells in Patients with ANCA-Associated Vasculitis.

Authors:  Ying Xu; Hongmei Xu; Yu Zhen; Xueting Sang; Hao Wu; Cong Hu; Zhanchuan Ma; Miaomiao Yu; Huanfa Yi
Journal:  Mediators Inflamm       Date:  2019-12-02       Impact factor: 4.711

7.  Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells.

Authors:  Luisa Bell; Alexander Lenhart; Andreas Rosenwald; Camelia M Monoranu; Friederike Berberich-Siebelt
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

Review 8.  Follicular regulatory T cells: a novel target for immunotherapy?

Authors:  Yao Huang; Zhe Chen; Hui Wang; Xin Ba; Pan Shen; Weiji Lin; Yu Wang; Kai Qin; Ying Huang; Shenghao Tu
Journal:  Clin Transl Immunology       Date:  2020-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.